Akari Therapeutics (AKTX) Shares Issued (2016 - 2026)

Akari Therapeutics (AKTX) has reported Shares Issued for 11 consecutive years, with $154.5 million the latest figure, recorded in Q1 2026.

• Quarterly Shares Issued fell 98.93% year-over-year to $154.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $154.5 million (down 98.93% YoY) and the FY2025 annual result came in at $170137.0, down 100.0% from the prior year.
• Shares Issued grew to $154.5 million in Q1 2026 per AKTX's latest filing, from $170137.0 in the prior quarter.
• Over the last five years, Shares Issued for AKTX reached as high as $19.2 billion in Q2 2025 and fell as low as $170137.0 in Q4 2025.
• A 5-year average of $4.0 billion and a median of $513.7 million in 2022 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2024 — Shares Issued surged 343268.0% — and 2025, when it plunged 100.0%.
• Year by year, Shares Issued stood at $513.7 million in 2022, then plunged by 99.61% to $2.0 million in 2023, then jumped by 343268.0% to $6.8 billion in 2024, then tumbled by 100.0% to $170137.0 in 2025, then surged by 90706.82% to $154.5 million in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $154.5 million, $170137.0, and $7.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.